logo

Tyme Technologies, Inc. (TYME)



Trade TYME now with
  Date
  Headline
3/27/2018 8:12:12 AM Tyme Announces First Site Open For Its Phase II Trial With SM-88 In Pancreatic Cancer
3/14/2018 8:07:59 AM Tyme Technologies: FDA Accepts IND Application To Initiate Phase II Clinical Trial For SM-88 In Pancreatic Cancer
3/8/2018 8:11:34 AM Tyme Technologies Reports Closing Of Public Offering Of Common Stock
3/1/2018 10:00:55 PM Tyme Technologies Prices Public Offering Of 9 Mln Shares At $2.25/shr
2/21/2018 9:01:07 AM Tyme Technologies Appoints Tommy Thompson To Board